Brutalist Biotech
Max
3
|
5
|
10
|
20
items per feed.
Cutting-edge Biotech news: Presented the old-fashioned way.
Fierce Biotech
Clario acquires WCG's neuroscience-focused clinical outcome assessment business
(1d)
Insilico Medicine raises $110M for new trials and robotic helping hands
(1d)
J&J’s Monarch bronchoscopy robot cleared by FDA to connect to live CT scans
(1d)
BioPharma Dive
MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup
(3h)
Mallinckrodt, Endo to combine in $7B deal
(5h)
Roche broadens obesity drug plans with $1.65B Zealand deal
(1d)
Endpoints News*
MeiraGTx partners with cryptic AI startup Hologen to advance Parkinson's gene therapy
(4h)
With Hinge Health filing to go public, are we... back?
(4h)
Acelyrin, Pliant turn to ‘poison pill’ as Kevin Tang’s Concentra pursues both companies
(5h)
BioSpace
Trump Administration Pulls CDC Nominee Dave Weldon at Last Minute
(5h)
Houston’s Life Sciences Scene Continues Boosting Its Reputation
(5h)
Acelyrin Adopts Poison Pill to Ward Off Tang Capital Buy
(6h)
Stat News*
Study reveals how often medical device makers report safety incidents late to FDA
(4h)
Trump’s picks to run FDA and NIH win approval from Senate’s health committee
(6h)
A study on brains and a statement on driving
(6h)
BioPharma Trend
Elsevier Launches ScienceDirect AI to Provide Summarized Research Insights
(4h)
Elsevier Launches AI to Provide Summarized Research Insights
(7h)
Tempus Acquires AI-Powered Clinical Trial Matching Platform
(8h)
Labiotech.EU
Nine biotechs thriving in Seattle in 2025
(6h)
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
(1d)
The gender gap in clinical trials: Why women are still underrepresented
(2d)
GEN News
Mallinckrodt, Endo Plan $6.7B Merger
(1h)
Structure of Key Parkinson’s Disease Protein, PINK1, Seen for First Time
(2h)
Batavia Biosciences Partners with VBC and MEVAC to Advance Localized Vaccine Manufacturing in Egypt
(2h)
Cure Today
Dr. Kevin Kalinsky Covers Targeted Therapy in HER2– Breast Cancer
(1h)
Trusting My Stage 4 Breast Cancer Body
(3h)
ctDNA Testing May Offer Patients With RCC ‘Peace of Mind’
(4h)
Contract Pharma*
What’s New: Business Updates from Across the OSD Sector
(4h)
Batavia Biosciences Partners with VBC & MEVAC to Enhance Vaccine Manufacturing Capabilities in Egypt
(4h)
Mallinckrodt and Endo Agree to Combine
(5h)
The Pharma Letter*
Gene therapy for Parkinson’s at heart of new AI collab
(49m)
Troubled Mallinckrodt and Endo to merge
(3h)
Salipro Biotech inks deal with Boehringer
(3h)
Targeted Oncology
Experts Discuss Tislelizumab’s FDA Approval in Esophageal Cancer
(1h)
Dr. Galsky’s Perspectives on the CheckMate 274 Data Results
(2h)
Clinical Perspectives for the Treatment of R/M NPC
(2h)
MedWatch*
AJ Vaccines' bylaws block CEO's wish for women on the board
(5h)
Genmab re-elects board of directors at AGM
(6h)
Eli Lilly chief's salary surged to USD 29.2m in 2024
(6h)
In The Pipeline
Crystallization Cages
(2h)
A Bifunctional Degrader Reads Out in Phase 3
(1d)
New Synthetic Antibiotics
(2d)
Pharmaphorum
Trump pulls CDC head nomination as FDA, CDC picks advance
(5h)
Insilico raises $110m for AI-designed drug pipeline
(6h)
'Transformational' pill for endometriosis gets NHS nod
(7h)
Drug Discovery Weekly
First patient dosed in gene therapy study for Stargardt disease
(3h)
New podcast: The revolutionary impact of understanding genomics
(5h)
The revolutionary impact of understanding genomics
(5h)
Reddit Biotech
Curve therapeutics
(12h)
Hot take
(12h)
Advice on moving into clinical roles
(16h)
Google News Biotech
George Church spinout GRObio explores strategic alternatives 6 months after Bayer-backed series B - Fierce Biotech
(2h)
Salipro Biotech inks deal with Boehringer
(3h)
Biotech Alert: Searches spiking for these stocks today - TipRanks
(3h)
* May require subscription